LOCATION

Saint Kate - The Arts Hotel
139 E Kilbourn Ave, Milwaukee, WI 53202

COURSE DIRECTORS

Binod Dhakal, MD
^{MEDICAL COLLEGE OF WISCONSIN}
Syed Abutalib, MD
^{AURORA ST. LUKE MEDICAL CENTER, ADVOCATE HEALTHCARE}
Mehdi Hamadani, MD
^{MEDICAL COLLEGE OF WISCONSIN}

Exclusive Promotion

To honor our frontline and allied health community, we are offering complimentary registration to NPs, PAs, Nurses, PharmDs, Medical Technologists, and Allied Health Professionals.

Please note: The deadline to take advantage of this promotion is September 15th. To ensure compliance, all registrants using this promotion will be required to show a matching professional ID at the check-in desk.

TARGET AUDIENCE

The target audience includes hematologists/oncologists, advanced practice providers, and oncology pharmacists involved in managing hematologic malignancies. The planning committee reflects this audience through multidisciplinary representation from academic and community settings, ensuring content is clinically relevant, practice-based, and applicable across diverse care environments.

LEARNING OBJECTIVES

1. Apply current evidence to optimize sequencing of cellular therapy, bispecific antibodies, antibody-drug conjugates, transplant, and targeted therapies across multiple myeloma, lymphoma, and myeloid malignancies.

2. Incorporate risk stratification, molecular profiling, and disease-specific prognostic factors into individualized treatment planning for patients with hematologic malignancies.

3. Evaluate emerging therapies and evolving standards of care in acute leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, lymphoma, and multiple myeloma to improve clinical decision-making.

4. Use case-based clinical reasoning to manage complex scenarios including early relapse, post-cellular therapy management, treatment resistance, and high-risk disease.

ACCREDITATION & CREDIT DESIGNATION

ACCREDITATION STATEMENT:

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Milwaukee Hematologic Malignancies Innovations. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for

Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians:

Amedco LLC designates this live activity for a maximum of 4.50 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.